Guanabenz Prevents d-Galactosamine/Lipopolysaccharide-Induced Liver Damage and Mortality.

Saved in:

Bibliographic Details
Title:	Guanabenz Prevents d-Galactosamine/Lipopolysaccharide-Induced Liver Damage and Mortality.
Authors:	Perego J; CIML, Aix-Marseille University, CNRS, INSERM, Marseille, France., Bourbon C; CIML, Aix-Marseille University, CNRS, INSERM, Marseille, France., Chasson L; CIML, Aix-Marseille University, CNRS, INSERM, Marseille, France., Laprie C; CIML, Aix-Marseille University, CNRS, INSERM, Marseille, France., Spinelli L; CIML, Aix-Marseille University, CNRS, INSERM, Marseille, France., Camosseto V; CIML, Aix-Marseille University, CNRS, INSERM, Marseille, France., Gatti E; CIML, Aix-Marseille University, CNRS, INSERM, Marseille, France.; Aveiro Health Sciences Program, Institute for Research in Biomedicine (iBiMED), University of Aveiro, Aveiro, Portugal.; International Associated Laboratory (LIA), CNRS 'Mistra', Marseille, France., Pierre P; CIML, Aix-Marseille University, CNRS, INSERM, Marseille, France.; Aveiro Health Sciences Program, Institute for Research in Biomedicine (iBiMED), University of Aveiro, Aveiro, Portugal.; International Associated Laboratory (LIA), CNRS 'Mistra', Marseille, France.
Source:	Frontiers in immunology [Front Immunol] 2017 Jun 13; Vol. 8, pp. 679. Date of Electronic Publication: 2017 Jun 13 (Print Publication: 2017).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1664-3224
DOI:	10.3389/fimmu.2017.00679